Studies of FRAXA and FRAXE in women with premature ovarian failure.
about
Microdeletions in FMR2 may be a significant cause of premature ovarian failureEvolutionary conservation and expression of human RNA-binding proteins and their role in human genetic diseaseStudy of the Genetic Etiology of Primary Ovarian Insufficiency: FMR1 GeneX-linked mental retardation (XLMR): from clinical conditions to cloned genes.Intermediate sized CGG repeats are not a common cause of idiopathic premature ovarian failureLinkage analysis of extremely discordant and concordant sibling pairs identifies quantitative trait loci influencing variation in human menopausal age.FMR1 premutation is an uncommon explanation for premature ovarian failure in Han Chinese.Approaches to identify genetic variants that influence the risk for onset of fragile X-associated primary ovarian insufficiency (FXPOI): a preliminary study.X inactivation plays a major role in the gender bias in somatic expansion in a mouse model of the fragile X-related disorders: implications for the mechanism of repeat expansion.FMR1 gene and fragile X syndrome.Imprinting effect in premature ovarian failure confined to paternally inherited fragile X premutationsElevated levels of FMR1 mRNA in carrier males: a new mechanism of involvement in the fragile-X syndrome.Premature ovarian failure in the fragile X syndrome.Prevalence and phenotype consequence of FRAXA and FRAXE alleles in a large, ethnically diverse, special education-needs population.Common genetic variants are significant risk factors for early menopause: results from the Breakthrough Generations Study.Ovarian function in girls and women with GALT-deficiency galactosemiaGenes and translocations involved in POF.Predictors and risk model development for menopausal age in fragile X premutation carriers.Intra-individual stability over time of standardized anti-Mullerian hormone in FMR1 premutation carriersSelected enquiries into the causation of premature ovarian failure.Clinical utility gene card for: fragile X mental retardation syndrome, fragile X-associated tremor/ataxia syndrome and fragile X-associated primary ovarian insufficiencyThe Repeat Expansion Diseases: The dark side of DNA repair.Chromatin changes in the development and pathology of the Fragile X-associated disorders and Friedreich ataxia.Ovarian abnormalities in a mouse model of fragile X primary ovarian insufficiency.EMQN best practice guidelines for the molecular genetic testing and reporting of fragile X syndrome and other fragile X-associated disordersSomatic expansion in mouse and human carriers of fragile X premutation alleles.Granulosa cell and oocyte mitochondrial abnormalities in a mouse model of fragile X primary ovarian insufficiency.Nonlinear association between CGG repeat number and age of menopause in FMR1 premutation carriers.Reproductive and menstrual history of females with fragile X expansionsPremutations in the FMR1 gene are uncommon in men undergoing genetic testing for spinocerebellar ataxia.Population-based estimates of the prevalence of FMR1 expansion mutations in women with early menopause and primary ovarian insufficiency.Importance of gene dosage in controlling dendritic arbor formation during development.Distribution of FMR1 and FMR2 Repeats in Argentinean Patients with Primary Ovarian Insufficiency.A service evaluation of women attending the menopause/premature ovarian failure clinic of a tertiary referral centre.Long CGG-repeat tracts are toxic to human cells: implications for carriers of Fragile X premutation alleles.The roles of Sp1, Sp3, USF1/USF2 and NRF-1 in the regulation and three-dimensional structure of the Fragile X mental retardation gene promoterNo evidence for parent of origin influencing premature ovarian failure in fragile X premutation carriers.Premature ovarian failure is associated with maternally and paternally inherited premutation in Brazilian families with fragile XIncreased frequency of occult fragile X-associated primary ovarian insufficiency in infertile women with evidence of impaired ovarian function.Intrinsic Disorder in Proteins with Pathogenic Repeat Expansions.
P2860
Q24681930-3F2EE622-F925-4A12-ABD6-6A705A9C3EE6Q26991754-374DB9E5-6892-4B9F-84E8-79E2D9789B91Q28077015-D6B82C2D-557D-4403-A5D5-A7168B81E913Q33205129-12E1C2ED-93C8-4719-B8E5-D2276C28E562Q33787119-68E7F802-8130-4840-BDA2-778A569F2B4CQ33910994-355D7D27-FB39-4CC5-B14E-FBFDD0BA77E4Q33933573-83A46C94-6033-419A-94C3-7C203F188695Q34013270-1FEE14A1-8104-4E96-8D1E-0EA55CDA0030Q34074533-D2D0DBD6-6D0A-4142-8F29-98AB7B8B8BCFQ34141674-695E23F0-B12E-4AA5-8914-EB25AA4C3E3BQ34145023-8F0B5304-69CA-449D-B5B7-3AE8BFB432CEQ34146206-C6C96716-C238-472F-B152-F8C16CD415E8Q34306135-B6ED1421-7EBC-45D5-B7DE-1B8FECF2DA9CQ34388858-773115C8-2575-4DC3-9129-FE9E0E1F6C15Q34399372-B7A2AFAE-497B-40B3-BABE-F6CF36B4B19BQ34714428-CABF47B1-8760-4D09-9F01-F8707827E6E2Q34811120-2EB951A1-BFA4-4CD6-B64F-360517664384Q35093727-804B278B-101E-4A8A-8AD6-A0E6E6E9B738Q35108269-031946A8-53D8-46F3-B9F7-BE8536D9B2ACQ35213827-4308DF87-D474-4B31-8743-1C6CE844E5A8Q35230078-00199941-717B-464B-857D-AF65B6326BF7Q35909014-3B92FE82-4DDB-4209-AD69-0987E18DD457Q36016607-66DC319C-D3CA-4CA6-91B5-F21E4AB43FB2Q36085633-F2CCEDB7-AFEE-401E-AC39-836BD3FD05E5Q36338209-A98B19FA-86FB-47B2-9C82-B22DA3B00853Q36472667-9C86F131-C332-4209-9B32-EA31235EAC05Q36946491-973F6AB8-BBBE-4BC9-9672-64A69FF6FF54Q37050617-5FEA2755-4898-4E32-A993-737D5909AF3BQ37050992-9CF74ED5-E5A7-4ED8-8036-7AE5F10D7F50Q37117706-648EAADC-F4BC-407F-895F-BA320C10BD22Q37555606-0A118156-814E-4D8B-9379-A13B0823F178Q38537122-01531DC8-73AC-411B-9598-69B19B55CBA8Q38622358-B079F0D2-8E1C-497A-AB3E-ECBD36BD9651Q39626945-EC9F3E4F-195F-42AA-A37A-5159104D142CQ40429123-42ED1FC7-3D20-40E9-A1E3-6E46B0745178Q40505209-77549B46-3273-4957-8F59-2FB698AA8247Q42693171-D2D48A1B-0338-4CD4-B26B-D8AA89B0DF25Q42693178-6DC12D36-5731-436E-9F0A-F6A7C96AD97EQ44357532-D4B5B6DE-ADF7-42C8-BF5B-DEF20AD020C3Q47351608-A675A87A-5D5B-4E86-80C3-3BDBD97B9AAA
P2860
Studies of FRAXA and FRAXE in women with premature ovarian failure.
description
1998 nî lūn-bûn
@nan
1998 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
1998 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
1998年の論文
@ja
1998年論文
@yue
1998年論文
@zh-hant
1998年論文
@zh-hk
1998年論文
@zh-mo
1998年論文
@zh-tw
1998年论文
@wuu
name
Studies of FRAXA and FRAXE in women with premature ovarian failure.
@ast
Studies of FRAXA and FRAXE in women with premature ovarian failure.
@en
type
label
Studies of FRAXA and FRAXE in women with premature ovarian failure.
@ast
Studies of FRAXA and FRAXE in women with premature ovarian failure.
@en
prefLabel
Studies of FRAXA and FRAXE in women with premature ovarian failure.
@ast
Studies of FRAXA and FRAXE in women with premature ovarian failure.
@en
P2093
P2860
P356
P1476
Studies of FRAXA and FRAXE in women with premature ovarian failure.
@en
P2093
P2860
P304
P356
10.1136/JMG.35.8.637
P407
P577
1998-08-01T00:00:00Z